3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
32
Phase 1
10
Phase 3
9
Phase NA
8
Phase 1/2
5
Phase EARLY_PHASE1
2
Phase 4
2
Phase 2/3
2
Status
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
26
pembrolizumab
17
Specimen Handling
17
Radiotherapy
17
Nivolumab
15
Cyclophosphamide
14
Temozolomide
11
Biopsy
11
Fluorodeoxyglucose F18
10
fludarabine
9
X-Rays
9
Etoposide
7
Bevacizumab
7
Standard of Care
6
Radiation
6
Paclitaxel
6
Dexamethasone
6
Cisplatin
6
Carboplatin
6
Surgical Procedures, Operative
5
Ipilimumab
5
Doxorubicin
5
Aspirin
5
venetoclax
4
olaparib
4
fluciclovine F-18
4
atezolizumab
4
abemaciclib
4
Vincristine
4
Rituximab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Metformin
×
1 year
×
Clear all
NCT03905941
2026-02-23
SHK002
University of Virginia
Phase EARLY_PHASE1
Withdrawn
NCT05515978
2025-12-04
PragMet
University of Colorado, Denver
Phase EARLY_PHASE1
Recruiting
100 enrolled